ArticleDrug delivery2021

CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas.

Ling-Chun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.